limestone has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brophy, DF; Gehr, TW; Holdford, DA; Kennedy, DT; Wallace, JF | 1 |
| Lehtonen, A; Viikari, J | 2 |
| Ala-Kaila, K; Inkovaara, J; Koskinen, P; Nikkari, T; Salo, M | 1 |
| Buchwald, H; Clayman, RV; Fitch, LL; Gillis, M; Hruska, KA; Matts, JP; Obialo, CI | 1 |
| Bierenbaum, ML; Fleischman, AI; Lenz, PH | 1 |
| Bierenbaum, ML; Fleischman, AI; Raichelson, RI | 1 |
3 trial(s) available for limestone and Hyperlipemia
| Article | Year |
|---|---|
Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
Topics: Adult; Calcium Carbonate; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Middle Aged; Triglycerides; Xanthomatosis | 1979 |
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
Topics: Calcium; Calcium Carbonate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias | 1977 |
Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.
Topics: Adult; Alkaline Phosphatase; Calcium Carbonate; Cholesterol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Phosphates; Triglycerides | 1977 |
4 other study(ies) available for limestone and Hyperlipemia
| Article | Year |
|---|---|
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia.
Topics: Atorvastatin; Calcium Carbonate; Cost-Benefit Analysis; Decision Support Techniques; Epoxy Compounds; Health Care Costs; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoproteins, LDL; Phosphates; Polyamines; Polyethylenes; Pyrroles; Sevelamer | 2000 |
Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: case-control study. The POSCH Group.
Topics: Adult; Aged; Calcium Carbonate; Case-Control Studies; Diuresis; Female; Humans; Hyperlipidemias; Ileum; Male; Middle Aged; Postoperative Complications; Reference Values; Urinary Calculi | 1991 |
The hypolipidemic effect of calcium-containing compounds and vitamin D 2 in the rat.
Topics: Animals; Calcium; Calcium Carbonate; Cholesterol; Deficiency Diseases; Diet, Atherogenic; Dietary Fats; Ergocalciferols; Fatty Acids, Nonesterified; Feces; Glycerides; Hyperlipidemias; Magnesium; Male; Metabolism; Rats; Sterols; Triglycerides | 1972 |
Long term human studies on the lipid effects of oral calcium.
Topics: Administration, Oral; Adult; Body Weight; Calcium Carbonate; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged; Phenotype; Phospholipids; Time Factors; Triglycerides | 1972 |